Research
Energy balance
Bariatric surgery (Roux-en-Y gastric bypass and sleeve gastrectomy) is recommended for individuals with BMI > 35 kg/m² regardless of comorbidities, and for those with BMI 30-34.9 kg/m² and metabolic diseases.
Bariatric surgery is now recommended for individuals with a BMI over 35, even without other health issues, and for those with a BMI of 30-34.9 who have metabolic diseases. Procedures like Roux-en-Y gastric bypass and sleeve gastrectomy provide substantial long-term weight loss and improve quality of life.
StrongSupportsHIGH confidence
Recent guidelines for bariatric surgery indicate that surgical treatment is now recommended for individuals with a body mass index (BMI) greater than 35 kg/m², regardless of the presence of co-morbidities. Additionally, surgery should be considered for those with metabolic diseases and a BMI between 30 and 34.9 kg/m²
Why this rating
Based on recent guidelines and studies cited.
Source
The Growing Obesity Epidemic: Integrating Lifestyle, Pharmacological, and Surgical Interventions for Effective Management
Jan Siwiec et al. · Journal of Education Health and Sport · 2025
DOI 10.12775/jehs.2025.77.56962
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Tirzepatide, a dual GLP-1 and GIP receptor agonist, produces superior weight loss (up to 20.9%) and visceral fat reduction compared to other anti-obesity medications.Strong
- Semaglutide 2.4 mg administered weekly results in a mean weight loss of 14.9% over 68 weeks, significantly outperforming placebo.Strong
- High-intensity behavioral interventions involving at least 14 sessions over six months produce significant weight loss (5-10%) and improve glycemic control.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →